Masimo Corp. (MASI) – Business Wire
-
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
-
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
-
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
-
Politan Nominates Two Independent Candidates for Masimo Board
-
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
-
Masimo Named One of Fast Company’s Most Innovative Companies in North America
-
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
-
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
-
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
-
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
-
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
-
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
-
Masimo Announces New Member of the Board of Directors
-
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
-
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
-
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
-
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
-
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
-
Masimo to Present in Jefferies London Healthcare Conference
-
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
-
Masimo Announces New Member of the Board of Directors
-
Masimo Reports Third Quarter 2023 Financial Results
-
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
-
Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7
-
Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
-
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
-
Masimo to Present in Wells Fargo Healthcare Conference
-
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement
-
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
-
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
-
Masimo Reports Second Quarter 2023 Financial Results
-
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
-
Masimo Announces Preliminary Second Quarter 2023 Revenue Results
-
Politan Announces Shareholders Have Overwhelmingly Elected Both Its Director Nominees to Masimo's Board
-
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
-
Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis
-
Masimo Board of Directors Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card
-
Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)
-
Leading Proxy Advisory Firm Glass Lewis Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
-
Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
-
Masimo Board of Directors Highlights Value of Company’s Mission-Driven Innovation in Letter to Stockholders
-
Community Health System Expands Use of Multiple Masimo Technologies, System-wide
-
Politan Nominees Michelle Brennan and Quentin Koffey Send Letter to Masimo Shareholders
-
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
-
Masimo Chairman and CEO Joe Kiani Waives Rights Under Director Change-in-Control Provision
-
Politan Comments on Masimo’s Recent Board Announcement
-
Masimo to Present in Jefferies Healthcare Conference
-
Masimo Announces FDA 510(k) Clearance of Radius VSM™
-
Masimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of Company Nominees
Back to MASI Stock Lookup
